Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

Align Technology (ALGN) loses appeal as 9th circuit revives monopoly suit and orders trial

5 October 2026 · By · Wire by Fusion42

Published

5 October 2026

Topic

regulatory

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at newsquawk.com →

◆ Verified

Fusion42 · 5 October 2026 · Fusion42 review

The 9th Circuit Court reinstated the monopoly lawsuit against Align Technology, ordering a trial and reviving legal risks associated with the company's dominant position in the aligner market.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You face extended legal uncertainty from revived monopoly claims, which could heighten risk valuation and influence settlement timing for contentious IP and market control disputes.

◆ Coverage

1 source · 5 Oct 2026

◆ Related on Wire

◆ Topics

Healthantitrustlitigationmarket-powerlegal-overhangmonopoly